Results 241 to 250 of about 1,251,690 (298)

Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies

Advanced Healthcare Materials, EarlyView.
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best, Gizem Karabiyik, Gerd Geerling, Sarah Barbara Zwingelberg, Gregor Lang, Martin Humenik   +5 more
wiley   +1 more source

Combating Antimicrobial Resistance: A Pharmacist-Led PDCA Stewardship Program in a Tertiary Hospital [Letter]. [PDF]

Infect Drug Resist
Shan QQ.
europepmc   +1 more source

The effect of diagnosis-related group policy on treatment cost and treatment efficiency of inpatients with coronary heart disease in Xinjiang: an interrupted time series analysis. [PDF]

J Glob Health
Wang N, Yi H, Yang J, Aierken A, Wushouer H, Han S, Yao W.   +6 more
europepmc   +1 more source

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial. [PDF]

RMD Open
Holly T, Kirkesaether Brun M, Jørgensen KK, Goll GL, Sexton J, Gehin JE, Kvien TK, Jahnsen J, Provan SA, Bolstad N, Aas E, Haavardsholm EA, Kristiansen IS, Syversen SW, Hagen G.   +14 more
europepmc   +1 more source

A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome. [PDF]

Orphanet J Rare Dis
Manders E, Keestra S, Bannenberg W, van der Wel V, de Visser S, Hollak C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug costs.

Lancet (London, England), 1976
exaly   +5 more sources

Proposed Drug-Drug Cost Effectiveness Methodology

Drug Intelligence & Clinical Pharmacy, 1987
abstract: The advent of prospective reimbursement in hospitals has forced hospital administrators, pharmacy directors, and pharmacy and therapeutic committees to carefully compare the cost and benefits of similar drugs. Accomplishing this task is difficult.
Jean Paul, Gagnon, Jane T, Osterhaus
openaire   +3 more sources